Marinus pharmaceuticals Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Marinus pharmaceuticals Contact Number

Contact Us Marinus Pharmaceuticals : Marinus Pharmaceuticals

7 hours ago Marinuspharma.com Get All

484-801-4670

Contact Marinus Pharmaceuticals. First name Last name Email Country I am interested in receiving information about . Questions/comments . Headquarters. 5 Radnor Corporate Center, 100 Matsonford Rd, Suite 500 Radnor, PA 19087. Phone. Office 484-801-4670. General Inquiries. Please contact [email protected] Investor Inquiries. Please contact

Website: https://marinuspharma.com/contact-us/

Category: Contact SupportShow more

Home Marinus Pharmaceuticals : Marinus Pharmaceuticals

6 hours ago Marinuspharma.com Get All

Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety and convenient dosing for patients affected by epilepsy and CNS disorders.

Estimated Reading Time: 2 mins

Website: https://marinuspharma.com/

Category: Home PhoneShow more

Marinus Pharmaceuticals, Inc. Company Profile Radnor, PA

1 hours ago Dnb.com Get All

(484) 801-4670

Address. 5 Radnor Corporate Ctr Ste 500. Radnor , PA , 19087-4538. United States. See other locations. Phone. (484) 801-4670. Company Description. Marinus Pharmaceuticals is ready to put an end to epileptic seizures.

Tangible Fixed Assets: $1.95
TOTAL CURRENT ASSETS: $146.27
Total Assets: $150.46

Website: https://www.dnb.com/business-directory/company-profiles.marinus_pharmaceuticals_inc.d67fa99c5b258323b37c19596e7dc4d5.html

Category: Contact NumberShow more

Marinus Pharmaceuticals Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Get All

484-253-6792

Contact Email [email protected] Phone Number 484-253-6792 Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings.

Website: https://www.crunchbase.com/organization/marinus-pharmaceuticals

Category: Contact NumberShow more

Marinus Pharmaceuticals Company Profile Office Locations

Just Now Craft.co Get All

Marinus Pharmaceuticals has 740 Twitter Followers. The number of followers has increased 0.2% month over month and decreased 0.1% quarter over quarter

Founded: 2003
Website: marinuspharma.com
Type: Public

Website: https://craft.co/marinus-pharmaceuticals

Category: Contact NumberShow more

About Marinus Marinus Pharmaceuticals : Marinus

Just Now Marinuspharma.com Get All

About Marinus. Marinus is committed to improving the lives of patients living with seizure disorders. We are developing an investigational drug, ganaxolone, which is an innovative and much needed potential treatment option for children and adults. Ganaxolone, our leading drug candidate, is designed to …

Website: https://marinuspharma.com/about-marinus/

Category: Contact NumberShow more

Marinus Pharmaceuticals Email Format marinuspharma.com

6 hours ago Rocketreach.co Get All

Marinus Pharmaceuticals uses 2 email formats: 1. first_initial [email protected] (97.0%). Enter a name to find & verify an email >>> Rocketreach finds email, phone & social media for 250M+ professionals.

Website: https://rocketreach.co/marinus-pharmaceuticals-email-format_b5c1ab32f42e08db

Category: Contact NumberShow more

Terms of Use Marinus Pharmaceuticals : Marinus

9 hours ago Marinuspharma.com Get All

Marinus does not endorse the content, or any products or services available, on such sites. Nonetheless, Marinus seeks to protect the integrity of its website and the links placed upon it and therefore requests any feedback on not only this Website, but for sites it links to as well (including if a specific link does not work). 11. Trademarks

Website: https://marinuspharma.com/terms-of-use/

Category: Contact NumberShow more

Leadership Marinus Pharmaceuticals : Marinus Pharmaceuticals

1 hours ago Marinuspharma.com Get All

Leadership. Scott Braunstein, M.D. was appointed Chief Executive Officer of Marinus in August 2019, executive chairman in February 2019 and has served on our board since September 2018. Dr. Braunstein brings over 20 years of knowledge and experience from diverse biotechnology and pharmaceutical industry vantage points. Dr.

Website: https://marinuspharma.com/about-marinus/leadership/

Category: Contact NumberShow more

Marinus Pharmaceuticals Announces Inducement Grants Under

7 hours ago Us.acrofan.com Get All

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.

Website: https://us.acrofan.com/detail.php?number=528693

Category: Contact NumberShow more

Marinus Pharmaceuticals Wiki Finpedia

Just Now Finpedia.co Get All

1. Marinus Pharmaceuticals (MRNS) is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. The company's clinical stage product candidate, ganaxolone, is a positive allosteric modulator of GABAA being developed in three different dose forms: intravenous (IV), capsule and liquid. The multiple dose forms are intended to maximize the therapeutic range of ganaxolone for adult and pediatric patient populations, in acute and chronic care, and both in-patient and self-administered settings. Ganaxolone exhibits anti-seizure, anti-anxiety and anti-depressive actions via its effects on synaptic and extrasynaptic GABAA receptors.1

Website: https://finpedia.co/bin/Marinus%20Pharmaceuticals/

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. (MRNS) Company Profile

4 hours ago Finance.yahoo.com Get All

See the company profile for Marinus Pharmaceuticals, Inc. (MRNS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key

Website: https://finance.yahoo.com/quote/MRNS/profile

Category: Contact NumberShow more

Marinus Pharmaceuticals Provides Business Update and

7 hours ago Us.acrofan.com Get All

Ganaxolone development for RSE is being funded, in part, by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, under contract number 75A50120C00159. About Marinus Pharmaceuticals

Website: https://us.acrofan.com/detail.php?number=513691

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals

Just Now Ir.marinuspharma.com Get All

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.

Website: https://ir.marinuspharma.com/news/news-details/2021/Marinus-Pharmaceuticals-Announces-Exclusive-Collaboration-with-Orion-Corporation-for-European-Commercialization-of-Ganaxolone/default.aspx

Category: Contact NumberShow more

MARINUS PHARMACEUTICALS, INC. CORPORATE …

7 hours ago S25.q4cdn.com Get All

MARINUS PHARMACEUTICALS, INC. CORPORATE GOVERNANCE GUIDELINES The number of directors shall be established by the Board in accordance with the Certificate of Incorporation. The Certificate of Incorporation and the Bylaws provide for the high potential into contact with the Board. Attendance of non-directors at Board meetings is at

Website: https://s25.q4cdn.com/443656056/files/doc_downloads/2021/01/MRNS-Corporate-Governance-Guidelines-(2020)-625471-v4.pdf

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals

3 hours ago Ir.marinuspharma.com Get All

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, anti-depressant and anti-anxiety potential.

Website: https://ir.marinuspharma.com/news/news-details/2021/Marinus-Pharmaceuticals-Provides-Business-Update-and-Reports-Fourth-Quarter-2020-Financial-Results/default.aspx

Category: Contact NumberShow more

Marinus Pharmaceuticals Submits New Drug Application (NDA

6 hours ago Us.acrofan.com Get All

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.

Website: http://us.acrofan.com/detail.php?number=509882

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals

3 hours ago Ir.marinuspharma.com Get All

Ganaxolone development for RSE is being funded, in part, by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, under contract number 75A50120C00159. About Marinus Pharmaceuticals

Website: https://ir.marinuspharma.com/news/news-details/2021/Marinus-Pharmaceuticals-Provides-Business-Update-and-Reports-Second-Quarter-2021-Financial-Results/default.aspx

Category: Contact NumberShow more

Vincent Pieribone, CoFounder at Affinimark Technologies

4 hours ago Relationshipscience.com Get All

Affinimark Technologies, Inc. Marinus Pharmaceuticals, Inc. RelSci Relationships. 2569. Number of Boards. 1. Number of Awards. 1. Contact Data. Trying to get in touch with Vincent Pieribone? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!

Website: https://relationshipscience.com/person/vincent-pieribone-3712988

Category: Tech SupportShow more

MRNS Marinus Pharmaceuticals Inc. • BioPharmCatalyst

5 hours ago Biopharmcatalyst.com Get All

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the grant of inducement awards to five new employees.The Compensation Committee of the Board of Directors of Marinus approved the grant of non-qualified stock options to purchase an aggregate of 14,313 shares of its common

Website: https://www.biopharmcatalyst.com/company/mrns

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals

3 hours ago Ir.marinuspharma.com Get All

Marinus Pharmaceuticals, Inc . (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the appointment of Santiago Arroyo, M.D., Ph.D., to its Board of Directors. Dr. Arroyo brings more than 30 years of experience in academic neurology and pharmaceutical research and development.

Website: https://ir.marinuspharma.com/news/news-details/2021/Marinus-Pharmaceuticals-Further-Strengthens-Board-of-Directors-with-Appointment-of-Santiago-Arroyo-M.D.-Ph.D/default.aspx

Category: Contact NumberShow more

Marinus Pharmaceuticals Number of Employees 20132021

Just Now Macrotrends.net Get All

Marinus Pharmaceuticals number of employees from 2013 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Compare MRNS With Other Stocks. Marinus Pharmaceuticals Annual Number of Employees. 2020.

Website: https://www.macrotrends.net/stocks/charts/MRNS/marinus-pharmaceuticals/number-of-employees

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. Marinus Announces Onefor

5 hours ago Ir.marinuspharma.com Get All

- Shares of Common Stock Will Begin Trading on Split-Adjusted Basis on September 23, 2020 Marinus Pharmaceuticals, Inc . (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today announced that it will effect a one-for-four reverse stock split of its common stock at 5:00 pm ET today.

Website: https://ir.marinuspharma.com/news/news-details/2020/Marinus-Announces-One-for-Four-Reverse-Stock-Split/default.aspx

Category: Contact NumberShow more

Marinus Pharmaceuticals Shares Outstanding MRNS

3 hours ago Ycharts.com Get All

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 06/16 18:39 ET Marinus Pharmaceuticals Appoints Martha Manning as Vice President, General Counsel and Secretary

Website: https://ycharts.com/companies/MRNS/shares_outstanding

Category: Contact NumberShow more

Jobs with Marinus Pharmaceuticals, Inc.

Just Now Biospace.com Get All

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) - June 22, 2021. 6/22/2021. Marinus Pharmaceuticals, Inc., a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced the grant of inducement awards to five new employees.

Website: https://www.biospace.com/employer/544542/marinus-pharmaceuticals-inc-/

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. DEF 14A Apr. 14, 2021 5:07

9 hours ago Seekingalpha.com Get All

MARINUS PHARMACEUTICALS, INC. Aggregate number of securities to which transaction applies: If you would like to inspect the list, please contact Martha E. Manning, Esq., our Vice President

Website: https://seekingalpha.com/filing/5477562

Category: Contact NumberShow more

Marinus Pharmaceuticals Provides Business Update and

5 hours ago Finance.yahoo.com Get All

Most recently, he served as Chief Medical Officer of Momenta Pharmaceuticals. Second generation formulation of ganaxolone to be discussed during the Marinus

Website: https://finance.yahoo.com/news/marinus-pharmaceuticals-provides-business-reports-110000293.html

Category: Contact NumberShow more

Michael Burry is Loading Up on These 9 Stocks

6 hours ago Finance.yahoo.com Get All

7. Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Number of Hedge Fund Holders: 13 . Percentage Increase in Stake During Q2: 111%. Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) is a …

Website: https://finance.yahoo.com/news/michael-burry-loading-9-stocks-141528091.html

Category: Contact NumberShow more

Marinus Pharmaceuticals Inc Sample Contracts Law Insider

Just Now Lawinsider.com Get All

Marinus Pharmaceuticals Inc – EMPLOYMENT AGREEMENT. THIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of February 26, 2019 (the “Effective Date”), by and between Marinus Pharmaceuticals, Inc. (the “Company”), a Delaware corporation with offices at Three Radnor Corporate Center, 100 Matsonford Road, Suite 304, Radnor, PA 19087, and Scott Braunstein, an individual

Website: https://www.lawinsider.com/company/1267813/marinus-pharmaceuticals-inc

Category: Contact NumberShow more

Marinus Pharmaceuticals : Announces Exclusive

9 hours ago Marketscreener.com Get All

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.

Website: https://www.marketscreener.com/quote/stock/MARINUS-PHARMACEUTICALS-17053985/news/Marinus-Pharmaceuticals-Announces-Exclusive-Collaboration-with-Orion-Corporation-for-European-Comm-36050310/

Category: Contact NumberShow more

Were Hedge Funds Right About Marinus Pharmaceuticals Inc

6 hours ago Finance.yahoo.com Get All

Marinus Pharmaceuticals Inc (NASDAQ: MRNS) was in 16 hedge funds' portfolios at the end of the first quarter of 2021. The all time high for this statistic is 18. There were 17 hedge funds in our

Website: https://finance.yahoo.com/news/were-hedge-funds-marinus-pharmaceuticals-230030448.html

Category: Contact NumberShow more

Adjunctive Ganaxolone Treatment (Part A) in TSC Followed

7 hours ago Clinicaltrials.gov Get All

You have reached the maximum number of saved studies (100). To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Marinus Pharmaceuticals, Inc. More Information. Go to

Website: https://clinicaltrials.gov/ct2/show/NCT04285346

Category: Contact NumberShow more

Marinus Pharmaceuticals : Announces Inducement Grants

7 hours ago Marketscreener.com Get All

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.

Website: https://www.marketscreener.com/quote/stock/MARINUS-PHARMACEUTICALS-17053985/news/Marinus-Pharmaceuticals-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4-36389338/

Category: Contact NumberShow more

Ligand Enters Commercial License and Supply Agreements

2 hours ago Investor.ligand.com Get All

About Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) is a biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, demonstrated efficacy and safety, and convenient dosing to improve the lives of patients suffering from epilepsy and neuropsychiatric disorders.

Website: http://investor.ligand.com/press-releases/detail/321/ligand-enters-commercial-license-and-supply-agreements-with

Category: Contact NumberShow more

Marinus Pharmaceuticals (MRNS) Soars: Stock Adds 5.5% in

6 hours ago Finance.yahoo.com Get All

Marinus Pharmaceuticals, Inc. MRNS was a big mover last session, as the company saw its shares rise nearly 6% on the day.The move came on solid volume too …

Website: https://finance.yahoo.com/news/marinus-pharmaceuticals-mrns-soars-stock-143302106.html

Category: Contact NumberShow more

Harry T. Rein Board of Directors @ ANADIGICS

6 hours ago Crunchbase.com Get All

Currently, Mr. Rein serves on the Board of Directors of Anadigics (NASDAQ: ANAD), and Marinus Pharmaceuticals. Previously, Mr. Rein was a member of the Board of Directors of the National Venture Capital Association ("NVCA") and was the recipient of the 2002 NVCA Outstanding Service Award. Mr.

Website: https://www.crunchbase.com/person/harry-t-rein

Category: Contact NumberShow more

Marinus Pharmaceuticals Submits New Drug Application (NDA

7 hours ago Ca.finance.yahoo.com Get All

RADNOR, Pa., August 03, 2021--(BUSINESS WIRE)--Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the use of its lead product candidate ganaxolone, to treat seizures associated

Website: https://ca.finance.yahoo.com/news/marinus-pharmaceuticals-submits-drug-application-110500500.html

Category: Contact NumberShow more

MARINUS PHARMACEUTICALS, INC. : MRNS Stock Price

6 hours ago Marketscreener.com Get All

Marinus Pharmaceuticals Inc is a United States-based biopharmaceutical company. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric disorders such as epilepsy, post-traumatic stress, and fragile-x syndrome.

Website: https://www.marketscreener.com/quote/stock/MARINUS-PHARMACEUTICALS-17053985/

Category: Contact NumberShow more

MRNS: Average Analyst Price Target is $30.11

6 hours ago Stocknews.com Get All

Marinus Pharmaceuticals Inc's variance in analysts' estimates is less than 13.94% of all US stocks. MRNS has a greater number of analysts covering the stock than 96.7% of stocks in the small market cap category. The average analyst price target of MRNS is greater than 70.36% of stocks in the small market cap category.

Website: https://stocknews.com/stock/MRNS/price-target/

Category: Contact NumberShow more

Ganaxolone Expanded Access Program Compassionate Use

7 hours ago Clinicaltrials.gov Get All

Marinus Pharmaceuticals: ClinicalTrials.gov Identifier: NCT04678479 Other Study ID Numbers: 1042-CDD-EAP-3005 : First Posted: December 22, 2020 Key Record Dates: Last Update Posted: December 22, 2020 Last Verified: December 2020

Website: https://clinicaltrials.gov/ct2/show/NCT04678479

Category: Contact NumberShow more

Anton Gopka Managing Member ATEM Capital LinkedIn

3 hours ago Linkedin.com Get All

Anton Gopka is a Venture Capitalist and Entrepreneur. He is a Co-Founder and General Partner at ATEM Capital which manages an evergreen US biotech fund — Health Square Fund (www.atemcap.com

Title: Venture Investor & Deeptech …
Location: New York, New York, United States
1. 500+ connections

Website: https://www.linkedin.com/in/gobbs

Category: Contact NumberShow more

MRNS Stock Forecast, Price & News (Marinus Pharmaceuticals)

6 hours ago Marketbeat.com Get All

(484) 801-4670

How can I contact Marinus Pharmaceuticals? Marinus Pharmaceuticals' mailing address is 100 Matsonford Rd Suite 500, Radnor PA, 19087. The biopharmaceutical company can be reached via phone at (484) 801-4670 or via email at [email protected]

Website: https://www.marketbeat.com/stocks/NASDAQ/MRNS/

Category: Contact NumberShow more

Anand Mehra General Partner @ Sofinnova Investments

5 hours ago Crunchbase.com Get All

Anand Mehra, M.D., joined Sofinnova Ventures in 2007 as a Principal to focus on biopharmaceutical investing. Anand's diverse background equips him to work with entrepreneurs on scientific, clinical, and strategic levels. Currently, Anand is a director of Marinus Pharmaceuticals, active in Anthera and Prestwick Pharmaceuticals

Website: https://www.crunchbase.com/person/anand-mehra

Category: Contact NumberShow more

SRO List Food and Drug Administration

3 hours ago Accessdata.fda.gov Get All

DUNS NUMBER BUSINESS NAME COUNTRY NAME TICKER SYMBOL EXCHANGE NAME; 130307536 : Marani Brands, Inc. USA : MRIB : OTHER OTC Market : 130604353 : All American Pet Company, Inc.

Website: https://www.accessdata.fda.gov/scripts/SDA/sdNavigation.cfm?sd=srolist&displayAll=false&page=24

Category: Contact NumberShow more

MRNS Stock quote for MARINUS PHARMACEUTICALS, INC. …

4 hours ago Msn.com Get All

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance 4 days ago. AdChoices. AdChoices. AdChoices. Markets. DOW. DOW 34,869.63

Website: https://www.msn.com/en-us/money/stockdetails/fi-a1xxsm

Category: Contact NumberShow more

Marinus Pharmaceuticals, Inc. DEF 14A Apr. 27, 2020 4:43

9 hours ago Seekingalpha.com Get All

Aggregate number of securities to which transaction applies: (3) (the “Board”) of Marinus Pharmaceuticals, Inc. (“we,” “us,” or the “Company”) for the 2020 Annual Meeting of

Website: https://seekingalpha.com/filing/4945848

Category: Contact NumberShow more

Collegium Pharmaceutical Number of Employees 20142021

1 hours ago Macrotrends.net Get All

Collegium Pharmaceutical number of employees from 2014 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Collegium Pharmaceutical Inc. is a specialty pharmaceutical company.

Website: https://www.macrotrends.net/stocks/charts/COLL/collegium-pharmaceutical/number-of-employees

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is marinus pharmaceuticals inc?

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Ganaxolone is a positive allosteric modulator of GABA A receptors that acts on a well-characterized target in the brain known to have anti-seizure, antidepressant and anti-anxiety effects.

Where is marinus pharmaceuticals in radnor pa?

Marinus Pharmaceuticals' mailing address is 100 Matsonford Rd Suite 500, Radnor PA, 19087. The biopharmaceutical company can be reached via phone at 484-801-4670 or via email at [email protected]

When is the reverse split for marinus pharmaceuticals?

Marinus Pharmaceuticals's stock reverse split on the morning of Wednesday, September 23rd 2020. The 1-4 reverse split was announced on Tuesday, September 22nd 2020. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, September 22nd 2020.

Who is the chief commercial officer of marinus?

Christy Shafer is our Chief Commercial Officer. In this role, Ms. Shafer is leading the development of our commercial strategy and organization to take advantage of current market opportunities and to maximize growth of our portfolio.

Brand New Updated

Popular Brands

Merck
Man
Maaden
Mcx
Midea
Metro
Mapfre